RxDoctor Payments Data

Richard Dalaba

Surgical · Albany, NYNPI 1770745200

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $20,459 of the $26,171 with a category attached, or 78.2%. 8 manufacturers reported payments, led by Medical Device Business Services, Inc. at 53.7% of the total. Reporting peaked in 2021 at $10,661 and has fallen 91.3% since, to $927 in 2025. Among surgical clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$26,171in general payments, 2019–2025

Across 93 payments — averaging $281.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medical Device Business Services, Inc.$14K
  • Johnson & Johnson$8K
  • Zimmer Biomet$2K
  • Depuy Synthes Products, Inc.$1K
  • Stryker$378
  • Smith+Nephew$222
  • plus $202 from 2 others

What the payments were for

  • Consulting fees$20,45978%
  • Travel & lodging$2,3449%
  • Food & beverage$3,27012%
  • Education$980%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$26,171 in reported general payments places this provider in the 95th percentile of 1,544 surgical providers in New York.

See all surgical providers in New York

Medicare billing

Part B allowed, 2024
$104,447
Medicare patients
524
Services billed
7,645

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Celecoxib406$11,438
Cephalexin571$2,290
Oxycodone Hcl266$2,061
Tramadol Hcl299$1,295
Diclofenac Sodium69$965
CefuroximeCefuroxime Axetil35$811
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen37$517
Clindamycin Hcl81$296
Meloxicam71$272
Ciprofloxacin Hcl12$270
Gabapentin15$130
Ondansetron Hcl29$112
Cyclobenzaprine Hcl23$87
Ibuprofen16$86
Amoxicillin19$63

Paid to pharmacies, not to this prescriber.

Other surgical in Albany

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →